X
IRWD icon

Xponance’s Ironwood Pharmaceuticals IRWD Stock Holding History

Xponance’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.3K Buy
14,337
+1,918
+15% +$7.86K ﹤0.01% 1632
2025
Q4 		$41.9K Buy
12,419
+80
+0.6% +$208 ﹤0.01% 1534
2025
Q3 		$16.2K Hold
12,339
– – ﹤0.01% 1523
2025
Q2 		$8.85K Buy
12,339
+846
+7% +$664 ﹤0.01% 1507
2025
Q1 		$16.9K Buy
11,493
+183
+2% +$436 ﹤0.01% 1432
2024
Q4 		$50.1K Buy
+11,310
New +$45.9K ﹤0.01% 1402
2024
Q2 		– Sell
-14,229
Closed -$124K – 1343
2024
Q1 		$124K Buy
14,229
+73
+0.5% +$886 ﹤0.01% 1228
2023
Q4 		$162K Sell
14,156
-755
-5% -$7.47K ﹤0.01% 1178
2023
Q3 		$144K Buy
+14,911
New +$146K ﹤0.01% 1145

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Xponance's IRWD Position: Q1 2026 in Review

Xponance increased its Ironwood Pharmaceuticals (IRWD) stake by 15% in Q1 2026, buying an estimated $7.86K and bringing the position to 14,337 shares worth $50.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

Xponance first reported a position in IRWD in Q3 2023 and has held it in 9 quarters since. The position peaked at $162K in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Xponance held 14,337 shares of Ironwood Pharmaceuticals worth $50.3K as of Q1 2026.
  • Xponance bought 1,918 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $7.86K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1632 holding.
  • Xponance first reported a position in Ironwood Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
  • Xponance's Ironwood Pharmaceuticals position peaked at $162K in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.